HIV/AIDS

Investment approved for the 2024-2026 grant – GC#7 21,227,603 USD

TUBERCULOSIS

Investment approved for the 2024-2026 grant – GC#7 6,129,088 USD

MALARIA

Approved investment for the 2024-2026 grant – GC#7 29,581,210 USD